MSD and Daiichi Sankyo have announced first subject dosing in the IDeate-Prostate01 Phase III trial of ifinatamab deruxtecan ...

Michael Rowlands Jr. didn’t just bounce back after a cancer battle — he leveled up. Here’s his advice for others going ...